Molybdenum trioxide: Target Organs and Levels of Evidence for TR-462
Toxicology and Carcinogenesis Studies of Molybdenum Trioxide (CASRN 1313-27-5) in F344 Rats and B6C3F1 Mice (Inhalation Studies)
Chemical (Study Title) CASRN |
Peer Review Date | Route/Exposure Levels | Study Laboratory |
---|---|---|---|
Molybdenum trioxide 1313-27-5 |
Inhalation 0,1,100 MG/M3/10 PER GROUP |
Hazleton, Vienna |
Levels of Evidence: None
Chemical (Study Title) CASRN |
Peer Review Date | Route/Exposure Levels | Study Laboratory |
---|---|---|---|
Molybdenum trioxide 1313-27-5 |
12/05/1995 | Inhalation R&M: 10, 30, OR 100 MG/M3; 50/SEX/SPECIES/GROUP |
Battelle Northwest Laboratory |
Levels of Evidence
Male Rats: Equivocal Evidence
Type | Organ/Tissue (Lesion) |
---|---|
Neoplastic Lesions |
|
Non-Neoplastic Lesions |
|
Female Rats: No Evidence
Type | Organ/Tissue (Lesion) |
---|---|
Non-Neoplastic Lesions |
|
Male Mice: Some Evidence
Type | Organ/Tissue (Lesion) |
---|---|
Neoplastic Lesions |
|
Non-Neoplastic Lesions |
|
Female Mice: Some Evidence
Type | Organ/Tissue (Lesion) |
---|---|
Neoplastic Lesions |
|
Non-Neoplastic Lesions |
|